16^th World Congress on Vascular Dementia and Neurodegenerative Diseases May 18-19, 2020 Osaka, Japan

Conference Series is currently bringing “16th World Congress on Vascular Dementia and Neurodegenerative Diseases” (Vascular Dementia Congress 2020) programmed to be held during May 18-19, 2020 at Osaka, Japan. The conference invites all the participants across the globe to attend and share their visions and convey current developments in the field of Dementia and Neurodegenerative diseases.

The session will be organized around the theme ‘Share the vision on Vascular Dementia and Neurodegenerative diseases'. We will likely convey an extraordinary program which covers the complete range of research in Dementia issue and Neurodegenerative diseases and share the ethnically diverse meetings of different treatment methodology.

Vascular dementia Congress 2020 is a yearly meeting of Neuroscience organizations as well as Dementia committees to debate the future of the Vascular Dementia in terms of collaboration, structures and organizational development.

Target Audience:

Business ambassadors, Industrial Frontrunners, Stroke Scientists, Neuro Oncologists, CEO's and R&D Heads  from Industries, Directors, Neurologist, Neurosurgeons, Psychiatrist, Neuroscientist, Head of department, Professors and Students from Academia in the research of neurological disorders.

Exhibition:

Why exhibit?

Make sales

Debut new products

Profile your brand

Meet new business partners and suppliers

Develop key relationships

Educate healthcare, medical institutions and academia

Who you will meet?

Leaders in:

Neurology

Neurosurgery

Vascular Dementia

Dementia

Neurological Disorders

Neuro Degeneration

Cerebrovascular disorders

Spine & Spinal Disorders

Stroke

Brain Tumors & Neuro Oncology

Neuropsychiatry and Mental health

Neuropharmacology

Why to attend?

16th World Congress on Vascular Dementia and Neurodegenerative Diseases an unique of a kind gathering to unite global recognized scholastics in the field of neuroscience and neurology, Brain specialists, general wellbeing professionals, researchers, scholastic reviewers, industry specialists, researchers to trade about best in class investigation and modernizations.

Aim of this conference is inspire new ideas for treatment that will be beneficial across the spectrum of Vascular Dementia Congress 2020

16th World Congress on Vascular Dementia and Neurodegenerative Diseases is a yearly meeting of Neuroscience organizations as well as Dementia committees to debate the future of the vascular dementia in terms of collaboration, structures and executive development. Brain investigators, public health specialists, scientists, academic experts, Industry intellectuals, scholars to exchange about state of the art research and technologies. Intention of this conference is to inspire new ideas for treatment that will be favourable across the spectrum of Vascular Dementia Congress 2020. Conferences, National symposiums and Workshops provide a dedicated opportunity for the advancement, implementation and exchange of information about Vascular Dementia Congress 2020 and its associated areas.

Why Osaka?

Dementia predominantly occurs in older people and, in view of the current demographic trend, has become a major issue for society and health policy.  Currently around 130,000 people in Austria are suffering from some form of dementia and experts estimate that this number will double by 2050. Accounting for around 60 – 80% of cases, Alzheimer's disease is by far the most common form of dementia.

Osaka is the second biggest Metropolitan range in Japan. Glorify in the large number of individuals encountering mental issues excuse the perseverance of 40 affiliations and social orders subsidiary to Neuroscience in Osaka and Japan. Japan is dislodging towards contemporary brain research industry from its conventional "shinrigaku".

Otherwise called the "Country's Kitchen", Osaka is a noteworthy financial center point, facilitating almost 19 million individuals. The GDP in Osaka is about $341 Billion. Alongside Paris and London, it is a standout amongst the most gainful hinterlands on the planet. Osaka is the second most costly city for ostracize workers on the planet 2009.

Osaka is known for its cutting edge design, nightlife and healthy road nourishment. The sixteenth Century Osaka Castle is the real fascination in this city alongside the clamoring Umeda Underground Mall and Namba Park.

Osaka, in Japan is an international hub for transport and health care, and has emerged as a regional centre for the arts, fashion and entertainment. The city is well known for its vibrant street life and cultural landmarks. Osaka is rapidly growing amidst little urban planning and regulation has resulted in a haphazard cityscape and inadequate infrastructure systems.  The city grew rapidly during the 1960s through the 1980s and now exerts a significant impact on Japan's politics, economy, education, media and modern society.

Conference Highlights:

•           Dementia

•           Dementia stages

•           Vascular Dementia

•           Causes of Vascular Dementia

•           Symptoms of Vascular Dementia

•           Lewy Body Dementia

•           Diagnosis

•           Dementia Nursing

•           Dementia care management

•           Treatment

•           Animal models

•           Neurodegenerative diseases

•           Neurooncology and CNS

•           Neuropharmacology

•           Vascular cognitive impairment

•           Therapeutic targets

•           Clinical trials and drug development

•           Neuroimmunology

•           Neuroradiology

•           Neurotoxicity of drug abuse

Why to attend???

16th World Congress on Vascular Dementia and Neurodegenerative Diseases is a single forum to bring together worldwide eminent academics in the field of neuroscience and neurology, Brain investigators, public health experts, scientists, academic geniuses, industry researchers, scholars to exchange about state of the art research and skills.

Meet Your Target Market With members from around the world focused on learning about the latest innovations in screening and treatments for Vascular Dementia and Neurodegenerative diseases; this is your single best opportunity to reach the largest assemblage of participants from the Universities, Neurology research centers and hospitals and conduct demonstrations of new screening instruments, distribute information about novel agents and strategies, meet with highly affiliated speakers, showing of clinical trials as well as advancements in new Dementia and neurodegenerative therapies, current methods and controversies in psychic therapy and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques for screening as well as for treatment, and the newest updates in Vascular Dementia and Neurodegenerative disorders and treatments are hallmarks of this conference.

According to WHO 47.5 million people have dementia and every year 7.7 million new cases are appearing. By 2030 total cases of dementia is projected to be 75.6 million and almost triple by 2050 to 135.5 million. Alzheimer’s disease contributes 60-70 % of cases in dementia and second most common condition of dementia is vascular dementia which contributes 20% of cases all over the world. Total estimated cost of dementia is 818 billion US $ in 2015.

With members from around the world focused on learning about various Alzheimer’s disease and how to prevent the disorders. This is your best opportunity to reach the largest assemblage of participants from the entire world.

At the Dementia conferences and from the eminent people speech, you can update your knowledge about current situation of Dementia  research and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Dementia fields are hallmarks of this conference.

Intention of this conference is inspire new ideas for treatment that will be helpful across the spectrum of Vascular Dementia Congress 2020

Importance and scope

From every corner of the world, someone develops dementia every 3 seconds. This was an estimated value at 46.8 million people worldwide living with dementia in 2015 and the number is expected to be close to 50 million people in 2017. This number may double every 20 years, reaching 75 million in 2030 and 131.5 million in 2050. Mostly it is observed too be increased in developing countries. For now, 58% of people with dementia are living in low and middle income countries, may be, by 2050 this can rise to 68%.

Worldwide results of current meta-analysis reveal 44 million people (worldwide) suffered with vascular dementia during 2010 and expected to double every 20 years, to the number 65.7 million in 2030 and 115.4 million in 2050. In 2010, 58 per cent of all people with low or middle incomes were with dementia lived in countries. This proportion anticipated in increase to 63 per cent in 2030 and 71 per cent in 2050.The values are expected to double by 2030 and triple by 2050 to 115 million.

Glance at market of dementia:-

The total estimated worldwide cost of dementia is US$818 billion in 2015, which represents 1.09% of global GDP. By 2018, the global cost of dementia will rise above a US$ trillion.

This figure includes costs attributed to informal care (unpaid care provided by family and others), direct costs of social care (provided by community care professionals, and in residential home settings) and the direct costs of medical care (the costs of treating dementia and other conditions in primary and secondary care).

Direct medical care costs account for roughly 20% of global dementia costs, while direct social sector costs and informal care costs each account for roughly 40%. The relative contribution of informal care is greatest in the African regions and lowest in North America, Western Europe and some South American regions, while the reverse is true for social sector costs.

This means that if global dementia care were a country, it would be the 18th largest economy in the world. The annual costs exceed the market values of companies such as Apple (US $742 billion) and Google (US $368 billion). More information is available in our World Alzheimer Report 2015.suffer from Alzheimer’s disease.

Top Universities globally working in the field of vascular Dementia.

•         Harvard University

•         University College London

•         University of California--San Francisco

•         Stanford University

•         Massachusetts Institute of Technology

•         Johns Hopkins University

•         University of California--Los Angeles

•         University of California--San Diego

•         Columbia University

•         University of Oxford

•         Karolinska Institute

Top Hospitals Associated with Vascular Dementia Research in World.

•         John Hopkins Medicine

•         Massachusetts General Hospital

•         Siloam Hospitals

•         Mayo Clinic

•         The Mount Sinai Hospital

•         Jefferson Hospital for Neuroscience

•         Neurology Florida Hospital

•         UNM Neurology Centre

•         Tampa General Hospital

•         Huntington Hospital

•         EI Camino Hospital

There are above Companies Associated with Vascular Dementia Research in World.

•         Forest Laboratories

•         Janssen Pharmaceuticals

•         Novartis Pharmaceutical Corporation

•         Pfizer

•         Eisai

•         Actinogen Limited

•         Alector LLC

•         AlzProtect SAS

•         TauRx Therapeutics Ltd

Vascular Dementia 2019

The "11th International conference on Vascular Dementia" hosted by Conference Series llc LTD took place at Amsterdam, Netherlands during February 15-16, 2019.

Active participation and generous response were received from the Organizing Committee Members, Editorial Board Members of Conference Series llc LTD Journals as well as from eminent scientists, talented researchers and young student community.

Researchers and students who attended from different parts of the world have made the conference one of the most successful and productive events in 2019 from Conference Series llc LTD.

The conference was marked by the presence of renowned scientists, talented young researchers, students and business delegates driving the three days event into the path of success with thought-provoking keynote and plenary presentations highlighting the theme “ Decoding Dementia and Alzheimer” Conference Series llc LTD has taken the privilege of felicitating Vascular Dementia congress 2019 Conference Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event.

Conference Series llc LTD, on behalf of the conference sponsor, appreciates all the participants who put their efforts for this event and sincerely wishes them success in future endeavours.

The esteemed guests, Keynote speakers, well-known researchers, and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Vascular Dementia 2019 Conference.

We are glad to inform that all accepted abstracts for the conference have been indexed in Conference Series llc LTD “Journal of Alzheimer’s Disease & Parkinsonism” as a special issue.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums.

We sincerely thank the Organizing Committee Members for their gracious presence, support and assistance towards the success of Vascular Dementia 2019.

With the unique feedbacks from the conference, Conference Series llc LTD would like to announce the commencement of the 16th World Congress on Vascular Dementia and Neurodegenerative Diseases on May 18-19, 2020 at Osaka, Japan.

Let us meet again @ Vascular Dementia Congress 2020